期刊文献+

IgG4相关硬化性胆管炎一例并国内文献复习 被引量:5

IgG4-related sclerosing cholangitis: a case report and literature review
下载PDF
导出
摘要 目的探讨我国Ig G4相关硬化性胆管炎(Ig G4-RSC)的临床特点、治疗策略以及预后。方法收集国内资料完整的符合Ig G4-RSC诊断标准的36例病人结合我院诊治的一例进行研究分析,探讨该病的临床特点、诊断、治疗以及预后。结果男28例,女9例。好发年龄于50-60岁之间。常见的临床表现主要为梗阻性黄疸(89%)、上腹部不适或疼痛(49%)和消瘦(27%)。15例接受血清学Ig G4检查有14例(93%)升高。22例Ig G检查中21例(95%)升高,29例CA19-9检查中18例(62%)升高。影像学检查:37例中33例胆总管下段狭窄(89%),4例肝门区胆管和胆总管中下段狭窄(11%)。37例均合并自身免疫性胰腺炎(AIP),多发淋巴结肿大3例(7%)。14例接受外科手术,术后病理证实Ig G4-RSC,5例术后加用激素治疗。23例行激素治疗,其中6例施行胆管支架植入,症状均有缓解。6例复发,再次行激素治疗后症状缓解。结论 Ig G4-RSC好发于中老年男性,常以梗阻性黄疸就诊,血清学检查Ig G4多有升高,常合并有自身免疫性胰腺炎,病理学检查有助于诊断(术前较难获得),激素治疗有效,复发再次激素治疗,症状仍能缓解。 Objective To explore the clinical characteristic and treatment strategy of Chinese IgG4-related sclerosing cholangi- tis. Methods 37 cases of IgGg-RSC reported in China were reviewed retrospectively with their clinical characteristic, diagnosis, treatment, and outcome. Results the main clinical manifestations are obstructive jaundice(89% ,33/37 ) ,upper abdominal discomfort or pain in 18 (49%) patients, emaciation in 10 (27 % ) patients. Immnnoglobulin (IgG) has been detected among 22 cases,21 (95 % ) cases increased, IgG4 is checked in 14 cases, 13 (92%) cases increased. CA19-9 have been examined in 29 cases, 18 (62%) cases are positive. Imaging examination findings implied that stenosis is located only in the lower part of the common bile duct in 33 (89%) cases, Stenosis is detected in both the hilar hepatic lesions and the lower part of the common bile ducts in 4 ( 11% ) cases, no case is found in stenosis diffusely distributed in the intra- and extrahepatic bile ducts or strictures of the bile duct only in the hilar hepatic. 37 (100%) cases are complicated with autoimmune pancreatitis. 14 cases accepted surgical treatment, Postoperative pathology confirmed IgGg-RSC, 23 cases accepted hormone therapy, the clinical symptoms were eased. 6 cases were relapse, but they were remission after using hormone again. Conclusions IgG4-RSC often occurs in middle-aged men around 58y, most with obstructive jaundice, with IgG4 increasing, with autoimmune pancreatitis, sensitive to hormone therapy,if relapse,hormone therapy was still effective.
出处 《肝胆外科杂志》 2015年第2期117-120,共4页 Journal of Hepatobiliary Surgery
关键词 IGG4 胆管炎 胰腺炎 治疗 诊断 IgG4 Cholangitis Pancreatitis Therapy, Diagnosis
  • 相关文献

参考文献13

二级参考文献78

共引文献102

同被引文献55

  • 1Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spec- trum, and outcomes of primary sclerosing cholangitis in a United States community [ J ]. Gastroenterology, 2003,125 (5) : 1364- 1369. DOI: 10. 1053/S0016-5085 (03)01356-8.
  • 2Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis [J]. Gut, 1996,38(4) :610-615.
  • 3Farrant JM, Hayllar KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis[ J]. Gas- troenterology, 1991,100(6) :1710-1717.
  • 4Kingham JG, Kochar N, Gravenor MB. Incidence, clinical pat- terns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom [ J ]. Gastroenterology, 2004,126 ( 7 ) : 1929-1930. DOI: 10. 1053/j. gastro. 2004.04.051.
  • 5Ponsioen CY, Vrouenraets SM, Prawirodirdjo W, et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population [ J ]. Gut, 2002,51 (4) : 562-566. DOI : 10.1136/gut. 51.4. 562.
  • 6Tischendorf JJ, Hecker H, Kruger M, et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis : A single center study [ J ]. Am J Gastroenterol, 2007, 102 ( 1 ) : 107-114. DOI : 10.1111/j. 1572-0241. 2006. 00872. x.
  • 7Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclero- sing cholangitis: natural history, prognostic factors and survival a- nalysis[J]. Hepatology, 1989, 10(4) :430-436. DOI: 10. 1002/ hep. 1840100406.
  • 8Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis [ J ]. J Hepatol, 2002,36 (3) :321-327. DOI: 10. 1016/S0168-8278 (01)00288-4.
  • 9Bjornsson E, Chaff ST, Smyrk TC, et al. lmmunoglobulin G4 as- sociated cholangitis: description of an emerging clinical entity based on review of the literature[ J]. Hepatology, 2007, 45 (6) : 1547-1554. DOI:10. 1002/hep. 21685.
  • 10Chapman R Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangistis [ J 1. Hepatology, 2010,51 ( 2 ) : 660-678. DO1 : 10. 1002/hep. 23294.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部